/cloudfront-us-east-2.images.arcpublishing.com/reuters/3JANUNFCQBMEXCYCF54KK2G24I.jpg)
A street sign for Wall Street hangs in front of the New York Stock Exchange May 8, 2013. REUTERS/Lucas Jackson/File Photo Acquire Licensing Rights NEW YORK, Dec 5 (Reuters) – Global bank executives said that dealmaking conditions have begun to improve, with some predicting a better outlook for strategic mergers and acquisitions at an industry … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/DFDHB46U3RJQJD2BKMQFJQTU54.jpg)
An Aspen Pharmacare logo is seen at outside company offices in Woodmead, Johannesburg, South Africa, September 13, 2018. REUTERS/Siphiwe Sibeko/File Photo Acquire Licensing Rights JOHANNESBURG, Dec 4 (Reuters) – Aspen Pharmacare (APNJ.J) is expanding further into China through a deal to buy the Chinese business of Swiss group Sandoz (SDZ.S) for up to 92.6 million … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MD32VUIFXVIFHDYZQNZKV2OKKI.jpg)
TOKYO/BEIJING, Nov 14 (Reuters) – If Japanese Prime Minister Fumio Kishida meets Chinese President Xi Jinping for the first time in a year later this week, he will likely raise the case of a detained company executive that has dealt an outsized blow to their close economic ties. The employee of drugmaker Astellas Pharma (4503.T), … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QNLD5PNTZJLNHOKDCWUIG7Y2J4.jpg)
FILE PHOTO: The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing Rights LONDON, Nov 13 (Reuters) – Novo Nordisk (NOVOb.CO) shares rose 3% on Monday as the market reacted to data the drugmaker presented over the weekend showing that the heart protective benefits of its popular obesity … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7XXQIDEIWRKN3NZA62CUCEHSMM.jpg)
A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights PHILADELPHIA, Nov 11 (Reuters) – Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HEW3P5TQNFJJHA6TMOOULJCXIA.jpg)
[1/3]A Louis Vuitton logo is seen outside a store on the Champs-Elysees avenue in Paris, France, June 27, 2023. REUTERS/Stephanie Lecocq/File Photo Acquire Licensing Rights LONDON/PARIS, Oct 9 (Reuters) – Europe’s luxury brands may have sparkled at Paris Fashion Week, but investors are questioning their taste for the shares in the face of a Chinese … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IMJOJGSZMZNHXG4AMJKCDAQOYY.jpg)
Bottles of prescription painkillers Oxycodone Hydrochloride, 30mg pills, made by Mallinckrodt sit on a counter at a local pharmacy, in Provo, Utah, U.S., April 25, 2017. REUTERS/George Frey/File Photo Acquire Licensing Rights Sept 18 (Reuters) – Bankrupt drugmaker Mallinckrodt is in talks with major investors about selling some or all of its business units, which … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FAQTJ67KUNKL3H6NZ4DIJMOMOI.jpg)
The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler/File Photo Acquire Licensing Rights Sept 8 (Reuters) – Eli Lilly’s (LLY.N) diabetes drug Mounjaro has gained … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LWL5MQN3BFLYLEKKBT47G7C4OQ.jpg)
[1/5]PhD student, Mehmet Yunus Comar, looks at a model of an early-stage human embryo, created by Israeli scientists without using an egg, sperm or womb, offering a glimpse into the first weeks of embryonic development, in a laboratory at the Weizmann Institute of Science in Rehovot, Israel September 7, Acquire Licensing Rights Read more REHOVOT, … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HLLQH3RSGJPC3BY5YOQNZDHTAE.jpg)
A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights Novo announces launch of Wegovy in the United Kingdom Novo says launch will be “controlled and limited” Drug to be available through specialist NHS scheme and … Read more